Immunology of reproduction: Protecting the placenta

Current Biology

Volumn 10, Issue 10, 2000, Pages

  Morgan, B Paul ^a   Holmes, Christopher H ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0034193820     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(00)00476-0     Document Type: Review

References (21)

1. Morgan B.P. Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci. 32:1995;265-298.
2. Atkinson J.P., Farries T.C. Separation of self from non-self in the complement system. Immunol Today. 8:1987;212-215.
3. Morgan B.P., Harris C.L. Complement regulatory proteins. 1999;Academic Press, London.
4. Matsuo S., Ichida S., Takizawa H., Okada N., Baranyi L., Iguchi A., Morgan B.P., Okada H. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med. 180:1994;1619-1627.
5. Nishikawa K., Matsuo S., Okada N., Morgan B.P., Okada H. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase. J Immunol. 156:1996;1182-1188.
6. Li B., Sallee C., Dehoff M., Foley S., Molina H., Holers V.M. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol. 151:1993;4295-4305.
7. Sun X., Funk C.D., Deng C., Sahu A., Lambris J.D., Song W.C. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci USA. 96:1999;628-633.
8. Xu C., Mao D., Holers V.M., Palance B., Cheng A.M., Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science. 287:2000;498-501.
9. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., Han S., Kelsoe G., Howard R.G., Rothstein T.L.et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol. 157:1996;549-556.
10. Stirrat G.M. Recurrent spontaneous abortion. Coulam C.B., Faulk W.P., McIntyre A. Immunological Obstetrics. 1992;357-376 WW Norton & Co, New York.
11. Tedesco F., Radillo O., Candussi G., Nazzaro A., Mollnes T.E., Pecorari D. Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin Exp Immunol. 80:1990;236-240.
12. Holmes C.H., Simpson K.L., Wainwright S.D., Tate C.G., Houlihan J.M., Sawyer I.H. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol. 144:1990;3099-3105.
13. Holmes C.H., Simpson K.L. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. Baillieres Clin Obs Gynae. 6:1992;439-460.
14. Holmes C.H., Simpson K.L., Okada H., Okada N., Wainwright S.D., Purcell D.F., Houlihan J.M. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol. 22:1992;1579-1585.
15. Okada N., Harada R., Taguchi R., Okada H. Complete deficiency of 20 kDa homologous restriction factor (HRF20) and restoration with purified HRF20. Biochem Biophys Res Comm. 164:1989;468-473.
16. Lublin D.M., Mallinson G., Poole J., Reid M.E., Thompson E.S., Ferdman B.R. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood. 84:1994;1276-1282.
17. Weisman H.F., Bartow T., Leppo K.M., Marsh H.C. Jr., Carson G.R., Concino M.F. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 249:1990;146-151.
18. Piddlesden S.J., Jiang S., Levin J.L., Vincent A., Morgan B.P. Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. J Neuroimmunol. 71:1996;173-177.
19. Ryan U.S. Complement inhibitory therapeutics and xenotransplantation. Nature Med. 1:1995;967-968.
20. Hunt J.S. Immunobiology of pregnancy. Curr Opin Immunol. 4:1992;591-596.
21. Wood G.W. Is restricted antigen presentation the explanation for fetal allograft survival? Immunol Today. 15:1994;5-18.